CAMP4 Therapeutics Corporation
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 28 →InsidersNo open-market buys or sales.→HoldersJupiter Topco 12.1%5AM Venture 11.3%FMR 9.4%→Financing →PeersClosest companies: PRAX, RLAY, FULC→
From the filings
Figures
- Revenue
- $4.2Mlast 12 months
- Net income
- −$107.2Mlast 12 months
- Operating cash flow
- −$26.2Mlast 12 months
- Cash and equivalents
- $86.4Mat the last balance sheet
- Shares outstanding
- 51.9M shareson issue